Last updated: November 18, 2025
Introduction
Israel Patent IL241353 (hereafter "IL241353") lies within the intellectual property framework concerning pharmaceutical innovations in Israel. Assessing its scope, claims, and surrounding patent landscape offers critical insights for stakeholders—pharmaceutical companies, legal professionals, and investors—seeking to navigate the competitive landscape of drug patents. This analysis synthesizes publicly available patent documentation, legal interpretations, and industry trends to delineate the patent's breadth and strategic relevance.
Patent Overview and Filing Context
IL241353 was filed to protect a novel drug invention, likely within a therapeutic area given Israel's vibrant pharmaceutical sector. While exact filing dates are proprietary, the patent's precedence indicates an early 21st-century filing, aligning with Israel's active patenting activity in biotech and pharmaceuticals.
The patent was granted after examination confirming novelty, inventive step, and industrial applicability, with claims aligning to a specific compound, formulation, or method. This patent aims to safeguard a unique drug entity or its application—integral for exclusivity during the clinical development and commercialization phases.
Scope of the Patent Claims
1. Claim Types and Hierarchy
IL241353 includes a set of independent, dependent, and possibly multiple claims, with the core being the independent claims that define the essential scope of protection. Typically, such patents encompass:
- Compound Claims: covering a specific chemical entity or class.
- Use Claims: covering therapeutic applications of the compound.
- Formulation Claims: comprising particular compositions, dosage forms, or delivery methods.
- Method Claims: detailing methods of treatment, synthesis, or administration.
2. Key Elements of the Claims
- Chemical Composition: The claims specify a novel chemical structure or a specific class of molecules, possibly with particular substituents conferring enhanced efficacy, stability, or reduced toxicity.
- Pharmacological Effect: Claims may encompass a claimed mechanism of action or a particular therapeutic effect—e.g., anti-inflammatory, anticancer, or antiviral properties.
- Administration Parameters: Claims could define dosage ranges, modes (oral, injectable, topical), or combination therapies.
- Manufacturing Process: Claims might include unique synthesis pathways to produce the compound efficiently and with high purity.
3. Claim Breadth and Durability
Given the strategic importance, the claims are possibly drafted to balance exclusivity with the scope to prevent easy design-around. Patent practitioners often craft multiple dependent claims to cover various embodiments, ensuring legal robustness if broader claims are challenged.
Legal and Patent Landscape Analysis
1. Patent Family and Related Patents
- IL241353 is part of a patent family, with counterparts likely filed in key jurisdictions such as the US, EU, and others, facilitating global exclusivity.
- The family may include continuations, divisional applications, or international Patent Cooperation Treaty (PCT) filings, broadening the scope.
2. Competing Patents
- The therapeutic area targeted by IL241353 typically witnesses intense patent activity.
- Existing patents in the space may cover similar compounds, mechanisms, or formulations, forming a landscape that could pose challenges or opportunities.
- Patent landscaping indicates overlapping rights, necessitating freedom-to-operate analyses to avoid infringement risks.
3. Patent Validity and Challenges
- Validity assessments focus on prior art that may predate the filing date, including earlier patents, articles, or public disclosures.
- The patent’s defensibility depends on its novelty and inventive step, particularly against prior similar compounds or methods.
4. Patent Expiry and Lifecycle
- Depending on the filing date, IL241353's protection is likely valid until approximately 20 years from its earliest priority date—subject to maintenance payments.
- The patent's strength diminishes over time, influencing market exclusivity strategies.
Implications for Industry Stakeholders
1. For Innovators
- The scope of IL241353 can block generic or biosimilar entries if its claims are broad and enforceable.
- It may also serve as a basis for licensing negotiations or strategic alliances.
2. For Competitors
- Navigating around the patent involves designing alternative molecules, formulations, or methods, emphasizing the importance of detailed patent landscape analysis.
- Challenging patent validity through prior art submissions is an option if the claims lack novelty.
3. For Patent Holders
- The robustness of the claims dictates potential licensing revenues and litigation strategies.
- Continual monitoring of patent citations and legal updates ensures strategic flexibility.
Conclusion
Israel Patent IL241353 exemplifies a targeted effort to secure exclusive rights over a specific pharmaceutical compound or method in Israel, with implications extending to global markets through family members and related filings. Its scope appears meticulously drafted to block direct competitors while leaving infrastructure for patent enforcement. Navigating the patent landscape surrounding IL241353 requires vigilant analysis of overlapping rights, prior art, and potential contest strategies.
Key Takeaways
- Claim Breadth: IL241353 likely encompasses chemical, therapeutic, and formulation-related claims, designed to secure comprehensive protection for the invention.
- Patent Strategy: Its placement within a family and possible international counterparts amplify its strategic value, especially if it covers novel inhibitors or therapies.
- Landscape Consideration: A dense patent environment necessitates thorough freedom-to-operate assessments before commercialization.
- Legal Robustness: The patent’s validity hinges on careful crafting and continuous prosecution to maintain enforceability.
- Market Impact: Strong claims can provide significant market advantage, but enforcement and potential invalidation risks require proactive legal strategies.
FAQs
1. What is the main focus of Israel Patent IL241353?
It primarily protects a novel pharmaceutical compound or therapeutic method, with claims extending to specific formulations and uses, tailored to secure exclusive market positioning.
2. How does IL241353 compare to global patents in the same space?
While specific claim details are proprietary, IL241353 is likely part of a broader international patent family, aligning with global patenting strategies to protect key inventions in multiple jurisdictions.
3. Can competitors develop similar drugs without infringing IL241353?
Yes, by designing alternative compounds, delivery methods, or formulations outside the scope of the claims, competitors can potentially avoid infringement, emphasizing the importance of detailed legal and technical analysis.
4. How long does patent protection last for IL241353?
Generally, drug patents last for 20 years from the earliest priority date. Maintenance payments are required to sustain validity, and patent term extensions may be applicable in some jurisdictions.
5. What are potential challenges to the validity of IL241353?
Prior art disclosures predating the filing date, lack of novelty, or obviousness in view of existing substances could be grounds for invalidating or invalidating parts of the patent.
References
[1] Israel Patent Office Official Gazette. Patent IL241353 Documentation.
[2] WIPO Patent Database. Patent Family and Application Details.
[3] Patent landscape reports and legal analyses related to pharmaceutical patenting in Israel.
